Dynamics of adreneractivity after transfer of myocardial infarction: annual observation

封面

如何引用文章

全文:

详细

Aim. To study the change in the β-adrenergic reactivity of red blood cell membranes in patients during the first year after acute myocardial infarction.

Materials and methods. The study included 25 patients with acute myocardial infarction (AMI) who signed informed consent to participate in the study. The erythrocyte membrane β-adrenoreactivity index (β-ARM) was determined in venous blood samples upon admission to the intensive care unit, one day after admission, 6 and 12 months after the index MI was transferred using the BETA-ARM-AGAT reagent kit (Agat-Med, Russia).

Results. According to the results of dynamics assessment of β-APM during the first day, patients included in the study were divided into 2 groups. Group 1 (n=14) included patients who had an increase in β-APM in the first day, and group 2 (n=21) included patients in whom β-ARM either did not change or decreased. At the time of admission to the hospital in the formed groups, there were no differences in the β-APM index and clinical and anamnestic characteristics. A day after hospitalization, the value of β-APM in group 1 significantly exceeded the same indicator in group 2 (p=0.02). At the periods of 6 and 12 months, the β-APM indices in the groups did not differ. In the 2nd group of patients, the progression of chronic heart failure to one or more functional classes (NYHA) was significantly more often compared with the 1st group.

Conclusion. The study showed that on the first day in patients with AMI, both an increase and a decrease in the activity of the sympathoadrenal system are possible with a further leveling of these differences over the next year. For a group of patients with decreased activity of sympathoadrenal system on the first day, a more unfavorable course of heart failure in the post-infarction period is characteristic.

作者简介

Tatiana Rebrova

Cardiology Research Institute, Tomsk National Research Medical Center

编辑信件的主要联系方式.
Email: rebrova@cardio-tomsk.ru
ORCID iD: 0000-0003-3667-9599

науч. сотр. лаб. молекулярно-клеточных патологии и генодиагностики

俄罗斯联邦, Tomsk

Elvira Muslimova

Cardiology Research Institute, Tomsk National Research Medical Center

Email: rebrova@cardio-tomsk.ru
ORCID iD: 0000-0001-7361-2161

науч. сотр. лаб. молекулярно-клеточных патологии и генодиагностики

俄罗斯联邦, Tomsk

Victoria Alexandrenko

Cardiology Research Institute, Tomsk National Research Medical Center

Email: rebrova@cardio-tomsk.ru
ORCID iD: 0000-0002-6717-5898

аспирант отд-ния патологии миокарда

俄罗斯联邦, Tomsk

Sergey Afanasiev

Cardiology Research Institute, Tomsk National Research Medical Center

Email: rebrova@cardio-tomsk.ru
ORCID iD: 0000-0001-6066-3998

д.м.н., проф., рук. лаб. молекулярно-клеточных патологии и генодиагностики

俄罗斯联邦, Tomsk

Alla Garganeeva

Cardiology Research Institute, Tomsk National Research Medical Center

Email: rebrova@cardio-tomsk.ru
ORCID iD: 0000-0002-9488-6900

д.м.н., проф., рук. отд-ния патологии миокарда

俄罗斯联邦, Tomsk

Ivan Maksimov

Cardiology Research Institute, Tomsk National Research Medical Center

Email: rebrova@cardio-tomsk.ru
ORCID iD: 0000-0003-0367-1654

д.м.н., проф., вед. науч. сотр. отд-ния неотложной кардиологии

俄罗斯联邦, Tomsk

参考

  1. Бойцов С.А., Проваторов С.И. Сердечно-сосудистые заболевания в Российской Федерации: основные составляющие смертности и направления профилактики. Вестник Росздравнадзора. 2018;5:12-8 [Boytsov SA, Provatorov SI. Cardiovascular diseases in the Russian Federation: the main components of mortality and areas of prevention. Bulletin of Roszdravnadzor. 2018;5:12-8 (In Russ.)].
  2. Драпкина О.М., Самородская И.В., Старинская М.А., Бойцов С.А. Сравнение российских регионов по уровню стандартизованных коэффициентов смертности от всех причин и болезней системы кровообращения в 2006–2016 гг. Профилактическая медицина. 2018;21(4):4-12 [Drapkina OM, Samorodskaya IV, Starinskaya MA, Boytsov SA. Comparison of Russian regions in terms of standardized mortality rates from all causes and diseases of the circulatory system in 2006–2016. Profilakticheskaya mediеtcina. 2018;21(4):4-12 (In Russ.)]. doi: 10.17116/profmed20182144
  3. Кузнецов В.А., Ярославская Е.И., Пушкарев Г.С. и др. Влияние плановых чрескожных коронарных вмешательств на показатели смертности населения Тюменской области. Рос. кардиологический журн. 2015;6:25-9 [Kuznetsov VA, Yaroslavskaya EI, Pushkarev GS, et al. Influence of planned percutaneous coronary interventions on mortality rates in the Tyumen region. Rossiiskii kardiologicheskii zhurnal. 2015;6:25-9 (In Russ.)]. doi: 10.15829/1560-4071-2015-06-25-29
  4. Никулина Н.Н., Якушин С.С. Современные аспекты формулировки диагноза и статистического учета инфаркта миокарда. Кардиология. 2016;56(9):60-6 [Nikulina NN, Yakushin SS. Modern aspects of the formulation of the diagnosis and statistical accounting of myocardial infarction. Kardiologiya. 2016;56(9):60-6 (In Russ.)]. doi: 10.18565/cardio.2016.9.60-66
  5. Шляхто В.Е., Конради А.О., Цырлин В.А. Вегетативная нервная система и артериальная гипертензия. СПб.: Медицинское издательство, 2008 [Shlyakhto VE, Konradi AO, Tsyrlin VA. Autonomic nervous system and arterial hypertension. Saint Petersburg: Meditsinskoe izdatel’stvo, 2008 (In Russ.)].
  6. Конради А.О. Вегетативная нервная система при артериальной гипертензии и сердечной недостаточности: современное понимание патофизиологической роли и новые подходы к лечению. Рос. кардиологический журн. 2013;4:52-63 [Konradi AO. The autonomic nervous system in arterial hypertension and heart failure: a modern understanding of the pathophysiological role and new approaches to treatment. Rossiiskii kardiologicheskii zhurnal. 2013;4:52-63 (In Russ.)]. doi: 10.15829/1560-4071-2013-4-52-63
  7. Стрюк Р.И., Длусская И.Г. Адренореактивность и сердечно-сосудистая система. М.: Медицина, 2003 [Stryuk RI, Dlusskaya IG. Adrenoreactivity and the cardiovascular system. Moscow: Meditsina, 2003 (In Russ.)].
  8. Shan K, Bick RJ, Poindexter BJ, et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol. 2000;36(3):891-6. doi: 10.1016/s0735-1097(00)00786-5

版权所有 © Consilium Medicum, 2021

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 
 


##common.cookie##